Vibeke Strand on Muck Rack

Vibeke Strand

Portola Valley
As seen in: Color Research & Application, Nature, Wiley Online Library, Annals of the Rheumatic Diseases, Educational Studies, Taylor & Francis Online, Arthritis Research & Therapy, Biomed Central (BMC), Medscape, Rheumatology and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Vibeke

Contact Vibeke, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual Meeting

|
By Sarah Romanelli, Beth Childs, Vibeke Strand, April Armstrong
| The Journal of Rheumatology Verified
Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual Meeting Sarah Romanelli, Beth Childs, Vibeke Strand, April W. Armstrong, Lourdes M. Perez-Chada, Joseph F. Merola, Alice B. Gottlieb The Journal of Rheumatology Aug 2025, jrheum.2025-0233; DOI: 10.3899/jrheum.2025-0233
Open in Who Shared Issue with article?

Sarilumab in relapsing polymyalgia rheumatica: patient-reported outcomes from a phase 3, double-blind, randomised controlled trial

|
By Vibeke Strand, Jérôme Msihid
| The Lancet Verified
Get full text access Log in, subscribe or purchase for full access. References 1. Gazitt, T ∙ Zisman, D ∙ Gardner, G Polymyalgia rheumatica: a common disease in seniors Curr Rheumatol Rep. 2020; 22:40 2. Devauchelle-Pensec, V ∙ Carvajal-Alegria, G ∙ Dernis, E ∙ et al. Effect of tocilizumab on disease activity in patients with active polymyalgia rheumatica receiving glucocorticoid therapy: a randomized clinical trial JAMA. 2022; 328:1053-1062 3.
Open in Who Shared Issue with article?

How JAK inhibitors tip the prothrombotic balance in rheumatoid arthritis - Nature Reviews Rheumatology

|
By Vibeke Strand
| Nature Verified
The increased incidence of deep vein thromboses and pulmonary emboli has long been noted in rheumatoid arthritis and has been ascribed to the effects of chronic inflammation and disease activity, as well as to specific biologic DMARDs and JAK inhibitors. Reporting in ACR Open Rheumatology, Zavoriti and Miossec provide data that might explain the prothrombotic effects of the JAK inhibitor tofacitinib.
Open in Who Shared Issue with article?
See all 60 licensed articles (74 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified